Methicillin-resistant Staphylococcus aureus in cystic fibrosis patients
do we need to care? A cohort study
Keywords:
Cystic fibrosis, Methicillin-resistant Staphylococcus aureus, Tomography, Spirometry, Body mass indexAbstract
CONTEXT AND OBJECTIVE: The prevalence of a variety of potentially pathogenic microorganisms in cystic fibrosis patients, such as methicillin-resistant Staphylococcus aureus (MRSA), has increased over the past decade. Given the increasing prevalence of MRSA and the few data available in the literature, better understanding of the clinical repercussions of colonization by this bacterium in cystic fibrosis patients becomes essential. This study aimed to evaluate the repercussions of chronic colonization by MRSA in cystic fibrosis patients. DESIGN AND SETTING: Retrospective cohort study from January 2004 to December 2013 in a cystic fibrosis reference center. METHODS: Each patient with cystic fibrosis was evaluated for nutritional status (body mass index, BMI, and BMI percentile), pulmonary function and tomographic abnormalities (modified Bhalla scores) at the time of chronic colonization by MRSA or methicillin-susceptible Staphylococcus aureus (MSSA) and throughout the study period. RESULTS: Twenty pairs of patients were included. There were no significant differences between the groups regarding nutritional characteristics. Spirometric data showed a trend towards greater obstruction of the airways in patients with MRSA. Patients with MRSA presented greater structural damage to their lungs, demonstrated not only by the total Bhalla score but also by its parameters individually. CONCLUSIONS: Patients colonized by MRSA presented greater functional and structural respiratory impairment at the time of chronic colonization. Disease progression was also faster in patients chronically colonized by MRSA than in those with MSSA. This was shown through comparisons that avoided possible confounding variables.
Downloads
References
Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care Med. 2003;168(8):918-51.
Dasenbrook EC. Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. Curr Opin Pulm Med. 2011 ;17(6):437-41.
Dasenbrook EC, Checkley W, Merlo CA, et al. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010; 303(23):2386-92.
Cystic Fibrosis Foundation Patient Registry. 2014 Annual Data Report. Bethesda: Cystic Fibrosis Foundation; 2015. Available from: https://www.cff.org/2014_CFF_Annual_Data_Report_to_the_Center_Directors.pdf/ Accessed in 2017 (May 2).
Sawicki GS, Rasouliyan L, Pasta DJ, et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2008;43(11):1117-23.
Zemanick ET, Harris JK, Conway S, et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros. 2010;9(1 ):1 -16.
Loeve M, Krestin GP, Rosenfeld M, et al. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J. 2013; 42(3):844-57.
Tddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev. 2006;7(3):202-8.
Bhalla M,Turcios N,AponteV, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991; 179(3)783-8.
Judge EP, Dodd JD, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest. 2006;130(5):1424-32.
Folescu TW, Marques EA, Boechat MC, et al. Escore tomográfico em pacientes com fibrose cística colonizados por Pseudomonas aeruginosa ou Staphylococcus aureus [High-resolution computed tomography scores in cystic fibrosis patients colonized with Pseudomonas aeruginosa or Staphylococcus aureus]. J Bras Pneumol. 2012;38(1 ):41 -9.
Gilligan PH, Kiska DL, Appleman MD. Cumitech 43: Cystic fibrosis microbiology. Washington: ASM Press; 2006.
Rosenstein BJ, Cutting GR.The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998;132(4):589-95.
Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4-S14.
Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178(8):814-21.
Cox DW, Kelly C, Rush R, et al. The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study. Ir Med J. 2011;104(10)305-8.
Vanderhelst E, De Meirleir L, Verbanck S, et al. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients. J Cyst Fibros. 2012;11 (1 ):2-7.
Centers for Disease Control and Prevention. BMI Percentile Calculator for Child and Teen. Available from: https://nccd.cdc.gov/dnpabmi/calculator.aspx Accessed in 2017 (May 2).
Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6)725-34.
Mehta G, Macek M Jr, Mehta A; European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros. 2010;9 Suppl 2:S5-S21.
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91-100.
Ren CL, Morgan WJ, Konstan MW, et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42(6):513-8.
Fermeiro J, Reis P, Castanhinha S, Pereira L, Barreto C.The impact of methicillin-resistant Staphylococcus aureus colonisation on paediatric cystic fibrosis patients'morbidity. Rev Port Pneumol. 2010;16(4):527-42.
Pereira FFL, Camargos PAM, Ibiapina CC, et al. Correlação entre escore de Bhalla e espirometria em crianças e adolescentes com fibrose cística [Correlation between Bhalla score and spirometry in children and adolescents with Cystic Fibrosis]. Rev Assoc Med Bras (1992). 2014;60(3):216-21.
Taccone A, Romano L, Marzoli A, et al. High-resolution computed tomography in cystic fibrosis. Eur J Radiol. 1992;15(2):125-9.
Santamaria F, Grillo G, Guidi G, et al. Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained? Pediatrics. 1998;101(5):908-13.
Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999;213(2):537-44.
de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology. 2004;231(2):434-9.
Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5(5):275-86.
Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41 (5):583-90.
